Analog of cannabidiol that is a potent agonist at the GPR55 cannabinoid receptor (EC50
values are 13, > 30000 and > 30000 nM for GPR55, CB1
receptors respectively). Induces activation of RhoA, cdc42 and rac1.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
The orphan receptor GPR55 is a novel cannabinoid receptor.
Ryberg et al.
The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects.
Johns et al.
The citations listed below are publications that use Tocris products. Selected citations for O-1602 include:
Showing Results 1 - 5 of 5